Full Schedule

08:00 - 08:45 CET

Industry Supported Session

08:00 - 08:45 CET

8th Bench-to-Bedside Uro-Oncology: GU Cancers Triad Meeting - Breakfast Symposia

08:00 - 09:00 CET

Moderated Oral/Video ePoster Sessions

09:00 - 10:45 CET

Plenary 03

Honorary Chair: – Istanbul Medipol University

Honorary Chair: – Tanta university, Egypt

09:00 - 09:03 CET

Welcome and Introductions

09:03 - 09:18 CET

SIU-Albert Schweitzer International Teaching Award Lecture

09:18 - 09:33 CET

Pan African Urological Surgeons Association (PAUSA) Lecture: Testosterone and Prostate Cancer - What Can We Learn from the Data of African Researchers

Speaker: – Sefako Makgatho Health Sciences University

09:33 - 09:48 CET

Urological Association Of Asia (UAA) Lecture: Value-Based Healthcare with Emerging Technology in Urology

Speaker: – University of the East Ramon Magsaysay Memoriia Medical Center College of Medicine

09:48 CET

Debate: Lymphadenectomy for Unfavorable Intermediate and High-risk Prostate Cancer for All or Risk-adapted

Moderator: – EHCS, Monash University

09:48 - 09:58 CET

For All

Speaker:

09:58 - 10:08 CET

Risk Adapted

Speaker: – University of Michigan

10:13 - 10:27 CET

Robotic Ureteral Reconstruction: From Grafts to Scaffolds

Speaker: – University of Queensland

10:27 - 10:41 CET

Game Changers in Endourology for KSD in 2026

Speaker: – "Saint John" Emergency Clinical Hospital

10:41 - 10:45 CET

Closing Remarks

10:45 - 11:15 CET

Industry Supported Session

10:45 - 11:15 CET

Networking Break

10:45 - 11:15 CET

Sponsored Symposia

13:15 - 17:30 CET

11th SIU Global Nurses Educational Symposium

Co-Chair: – Memorial Sloan-Kettering Cancer Center

Co-Chair:

14:00 - 15:30 CET

Best ePoster Presentations

14:00 - 15:30 CET

Controversies in Urology: Locally Advanced Bladder Cancer - Multidisciplinary Management After Systemic Therapy Response

Co-Chair: – Aga Khan University

Co-Chair: – Rajiv Gandhi Cancer Institute & Research Centre

Bladder Cancer

14:00 - 14:08 CET

Evolving Standards of Systemic Therapy in Locally Advanced and Metastatic Bladder Cancer Based on Global Access

Speaker: – Hassan II University Hospital

Bladder Cancer

14:08 - 14:16 CET

Imaging and staging of node-positive and M1a bladder cancer: CT vs PET and response assessment pitfalls

Speaker:

Bladder Cancer

14:16 CET

WHAT NEXT AFTER COMPLETE RESPONSE TO SYSTEMIC THERAPY IN N+/M1 DISEASE

Bladder Cancer

14:17 - 14:20 CET

DEBATE: N1/2 Disease After Response to Systemic Therapy - Post-response Local Management in N1/N2 Disease (Introduction)

Speaker: – Aga Khan University

Bladder Cancer

14:20 - 14:25 CET

Making a Case for Active Surveillance After Response in N1/2 Disease

Bladder Cancer

14:25 - 14:30 CET

Making a Case for Surgery After Response in N1/2 Disease

Bladder Cancer

14:30 - 14:35 CET

Making a Case for Bladder Preservation After Response in N1/2 Disease

Speaker:

Bladder Cancer

14:35 - 14:39 CET

N3 and M1a Disease After Response to Systemic Therapy (Introduction)

Speaker: – UT MD Anderson Cancer Center

Bladder Cancer

14:39 - 14:47 CET

Local consolidative approaches in N3 and oligometastatic M1a disease

Speaker: – Cedars-Sinai Medical Center

Bladder Cancer

14:47 - 14:55 CET

Would RC Ever Be an Option and Why?

Speaker: – McGill University Health Center

Bladder Cancer

14:55 - 15:03 CET

Precision and Risk-adapted Management in Metastatic UC - Treatment Breaks, Surveillance and Intensification Strategies Using ctDNA/MRD After Major Response

Bladder Cancer

15:03 - 15:30 CET

Case-based Panel - N2 MIBC, Not Responding to Therapy

Moderator: – UT MD Anderson Cancer Center

Bladder Cancer

14:00 - 15:30 CET

Hot Topic: Towards Perfection In Prostate Cancer Diagnosis

Co-Chair: – The Chinese University of Hong Kong

Co-Chair:

Prostate Cancer

14:00 - 14:15 CET

How Can We Reduce Metastatic Disease in the Developing World with Early Prostate Cancer Detection?

Speaker: – Beijing United Family Hospital and Clinics

Prostate Cancer

14:15 - 14:30 CET

PCa Screening Projects in Subsaharian Countries

Speaker: – Medical Faculty, Heinrich-Heine University Düsseldorf

Prostate Cancer

14:30 - 14:45 CET

Is There a Synergistic Role of Biomarkers and Advanced Imaging in Optimizing Diagnosis of Prostate Cancer?

Speaker: – University of Michigan

Prostate Cancer

14:45 - 15:00 CET

Can We Forget PSA and Use Biparametric MRI Prostate as a First Line Screening Tool ?

Speaker: – University of Palermo

Prostate Cancer

15:00 - 15:15 CET

The Current Status of AI In Prostate Cancer Diagnosis on MRI

Speaker: – University College London

Prostate Cancer

15:15 - 15:30 CET

Towards Prostate Cancer Diagnosis and Treatment Without a Biopsy

Speaker: – Medicity Guwahati

Prostate Cancer

14:00 - 15:30 CET

Instructional Course: Beyond the Standard: Selecting, Implanting, and Adjusting the Latest Adjustable Male Continence Devices

Chair: – Royal Berkshire NHS Foundation Trust

Voiding dysfunction

14:00 - 14:05 CET

Welcome and Introductions to the Devices

Speaker: – Royal Berkshire NHS Foundation Trust

Voiding dysfunction

14:05 - 14:20 CET

Non-Surgical Paceycuff: Indications, Suitability, and Waiting List Use

Voiding dysfunction

14:20 - 14:45 CET

Adjustable Sling ATOMS: Surgical Technique, Post-Op Adjustment and Outcomes

Speaker: – Royal Berkshire NHS Foundation Trust

Voiding dysfunction

14:45 - 15:10 CET

Artificial Sphincter Rigicon Conti-reflex: Design, Implantation and Comparison to AUS

Speaker: – Royal Berkshire NHS trust

Voiding dysfunction

15:10 - 15:30 CET

Panel Q&A and Clinical Case Discussions

Voiding dysfunction

14:00 - 15:30 CET

Interactive Session: Flaps, Grafts and MESH in Women’s Health

Co-Chair: – WARANA INSTITUTE OF UROSURGERY, KOLHAPUR, INDIA

Co-Chair: – UEM, Maputo Central Hospital

Reconstruction

14:00 - 14:12 CET

Advancing a Career in Reconstructive Urology

Speaker: – University College London & The London Clinic

Reconstruction

14:12 - 14:24 CET

Mixed Urinary Incontinence in Women

Speaker: – Midstream Mediclinic university of Pretoria

Reconstruction

14:24 - 14:36 CET

Buccal Mucosa Graft in Urethral Stricture in Women

Speaker: – WARANA INSTITUTE OF UROSURGERY, KOLHAPUR, INDIA

Reconstruction

14:36 - 14:48 CET

Surgical Management of Urethral Diverticulum

Speaker: – UROKUL

Reconstruction

14:48 - 15:00 CET

Advances in Treatment of Ureteric Injuries and Strictures

Speaker: – Tanta university, Egypt

Reconstruction

15:00 - 15:12 CET

Pelvic Floor Reconstruction Using Native Tissue, Mesh, and Robotic Techniques

Reconstruction

14:00 - 15:30 CET

Master Class: Artificial Intelligence in Urology - From Intelligent Operating Rooms to Digital Twin

Co-Chair: – USC Institute of Urology and Catherine and Joseph Aresty Department of Urology

Artificial Intelligence

14:00 - 14:10 CET

How Do We Standardise the Evaluation and Reporting of New AI Tools?

Speaker: – USC Institute of Urology and Catherine and Joseph Aresty Department of Urology

Artificial Intelligence

14:10 - 14:20 CET

AI, 3D Imaging, and Surgical Planning

Speaker: – HCG Cancer Center

Artificial Intelligence

14:20 - 14:30 CET

AI in Endoscopic Urology: Real-time Vision, Detection, and Support

Artificial Intelligence

14:30 - 14:40 CET

AI in Surgical Robots, Simulation, and Training

Artificial Intelligence

14:40 - 14:50 CET

AI Driven Interpretation and Educations in Surgical Operative Videos

Speaker: – Singapore General Hospital, Singapore

Artificial Intelligence

14:50 - 15:00 CET

AI in Pathology for Prostate and Bladder Cancer

Speaker:

Artificial Intelligence

15:00 - 15:10 CET

Human Digital Twins in Urology: Ethics and Responsibility

Artificial Intelligence

15:10 - 15:30 CET

Discussion & Q&A

Artificial Intelligence

15:12 - 15:30 CET

Discussion/Q&A

Reconstruction

16:00 - 17:30 CET

SIU Tips & Tricks: Office of Research